Molecular identification of yeast communities isolated from nail specimens by PCR-RFLP and PCR-FSP methods

Document Type : Original Articles

Authors

1 Department of Medical Parasitology and Mycology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran

2 Faculty of Medicine, Najafabad Branch, Islamic Azad University, Najafabad, Isfahan, Iran

Abstract

Background and Purpose: Onychomycosis is a common fungal infection that affects the nails, caused by various fungal agents. Moreover, yeast onychomycosis has increased in recent years. Yeast isolates might not be identified at the species level by conventional methods, whereas molecular methods can identify yeast isolates more accurately. This study aimed to identify yeast communities isolated from nail specimens by polymerase chain reaction (PCR)-restriction fragment length polymorphism (RFLP) and PCR- fragment size polymorphism (FSP) methods.
Materials and Methods: This experimental study was conducted on archival yeast isolates obtained from 269 patients suspected of onychomycosis who referred to the Medical Mycology Laboratory at Shiraz University of Medical Sciences in Shiraz, Iran, between April 2022 and March 2023. Onychomycosis was confirmed through direct examination and culture of nail specimens. The PCR-RFLP and PCR-FSP methods were used to identify yeast isolates.
Results: In total, 78 (28.99%) yeast strains were identified. Candida albicans was the most common species, followed by Candida parapsilosis complex and Candida tropicalis. Uncommon species of yeasts, such as Candida utilis, Candida pararugosa, Candida nivariensis, and Rhodotorula rubra were identified by molecular methods. The PCR-FSP method showed a strong agreement with the PCR-RFLP method in the identification of common yeast agents causing onychomycosis (κ=0.84).
Conclusion: It seems necessary to use molecular diagnostic tools in addition to conventional methods to identify yeast isolates in clinical laboratories. The rapid and accurate identification of fungal agents causing onychomycosis is useful for the selection of an appropriate treatment strategy.                  

Keywords

Main Subjects

References

  1. Zaraa I, Dehavay F, Richert B. Onychomycosis. Hand Surg Rehabil. 2024:101638.
  2. Piraccini BM, Alessandrini A. Onychomycosis: a review. J Fungi .2015;1(1):30-43.
  3. Giri Y, Habibullah S, Dixit PK, Mahalik G, Mohanty B, Behera A. Development of microemulgel formulations with varied permeation enhancers for transungual delivery of luliconazole in onychomycosis management. Colloids and Surfaces B: Biointerfaces. 2024;234:113718.
  4. Bitew A, Wolde S. Prevalence, risk factors, and spectrum of fungi in patients with onychomycosis in Addis Ababa, Ethiopia: a prospective study. J Trop Med. 2019;2019.
  5. Mohammadi R, Badiee P, Badali H, Abastabar M, Safa AH, Hadipour M, et al. Use of restriction fragment length polymorphism to identify Candida species, related to onychomycosis. Adv Biomed Res. 2015;4(1):95.
  6. Afsarian MH, Sharafi Z. Molecular Identification of Candida Species Isolated from Onychomycosis with In Vitro Antifungal Susceptibility Profiles. Jundishapur J Microbiol. 2023;16(8).
  7. Motamedi M, Ghasemi Z, Shidfar MR, Hosseinpour L, Khodadadi H, Zomorodian K, Mirhendi H. Growing Incidence of Non-Dermatophyte Onychomycosis in Tehran, Iran. Jundishapur J Microbiol. 2016;9(8):e40543.
  8. Verrier J, Pronina M, Peter C, Bontems O, Fratti M, Salamin K, et al. Identification of infectious agents in onychomycoses by PCR-terminal restriction fragment length polymorphism. J Clin Microbiol. 2012;50(3):553-61.
  9. Mohammadi R, Mirhendi H, Rezaei-Matehkolaei A, Ghahri M, Shidfar MR, Jalalizand N, et al. Molecular identification and distribution profile of Candida species isolated from Iranian patients. Med Mycol. 2013;51(6):657-63.
  10. Jafari Z, Motamedi M, Jalalizand N, Shokoohi GR, Charsizadeh A, Mirhendi H. Comparison of CHROMagar, polymerase chain reaction-restriction fragment length polymorphism, and polymerase chain reaction-fragment size for the identification of Candida Curr Med Mycol. 2017;3(3):10.
  11. EL-Mashad N, Raafat D, Elewa A, Othman W. Polymerase chain reaction-restriction fragment length polymorphism for characterization of Candida species causing onychomycosis. Journal of Advances in Medicine. 2012;1(2):77-84.
  12. Petinataud D, Berger S, Contet-Audonneau N, Machouart M. Molecular diagnosis of onychomycosis.
    J Mycol Med. 2014;24(4):287-95.
  13. Jafarian H, Khodadadi H, Badiee P. Development a hydrolysis probe-based quantitative PCR assay for the specific detection and quantification of Candida auris. Curr Med Mycol. 2020;6(3):50.
  14. Khodadadi H, Karimi L, Jalalizand N, Adin H, Mirhendi H. Utilization of size polymorphism in ITS1 and ITS2 regions for identification of pathogenic yeast species. J Med Microbiol. 2017;66(2):126-33.
  15. Chadeganipour M, Mohammadi R. Causative agents of onychomycosis: a 7‐year study. J Clin Lab Anal. 2016; 30(6):1013-20.
  16. Mohammadi R, Mirhendi H, Hedayati MT, Badali H. Caspofungin-Non-Susceptible Candida orthopsilosis isolated from onychomycosis in Iran. ran J Public Health. 2017;46(2):235.
  17. Trovato L, Calvo M, De Pasquale R, Scalia G, Oliveri S. Prevalence of onychomycosis in diabetic patients: a case-control study performed at university hospital Policlinico in Catania. J Fungi. 2022;8(9):922.
  18. Sakkas H, Kittas C, Kapnisi G, Priavali E, Kallinteri A, Bassukas I. Onychomycosis in Northwestern Greece over a 7-year period. Pathogens. 2020;9(10):851.
  19. Tabassum S, Rahman A, Awan S, Jabeen K, Farooqi J, Ahmed B, et al. Factors associated with onychomycosis in nail psoriasis: a multicenter study in Pakistan. Int J Dermatol. 2019;58(6):672-8.
  20. Yazdanpanah S, Jabrodini A, Motamedi M, Zomorodian K, Kharazi M, Shabanzadeh S, et al. Species distribution and antifungal susceptibility profiles of yeasts isolated from onychomycosis: a cross-sectional study with insights into emerging species. Antonie van Leeuwenhoek. 2024;117(1):6.
  21. Feng X, Ling B, Yang X, Liao W, Pan W, Yao Z. Molecular identification of Candida species isolated from onychomycosis in Shanghai, China. Mycopathologia. 2015;180:365-71.
  22. Karimi L, Mirhendi H, Khodadadi H, Mohammadi R. Molecular identification of uncommon clinical yeast species in Iran. Curr Med Mycol. 2015;1(2):1-6.
  23. Mirhendi S, Adin H, Shidfar M, Kordbacheh P, Hashemi S, Moazeni M, et al. Identification of pathogenic Candida species: PCR-fragment size polymorphism (PCR-FSP) method.Tehran Univ Med J 2008;66(9):639-45.
  24. Pakshir K, Zomorodian K, Zakaei A, Motamedi M, Ghiasi MR, Karamitalab M. Molecular identification and in-vitro antifungal susceptibility testing of Candida species isolated from patients with onychomycosis. Curr Med Mycol. 2015;1(4):26.
Current Medical Mycology
Volume 10, Issue 1
2024
Pages 1-5

Files

History

  • Receive Date: 21 May 2024
  • Revise Date: 22 June 2024
  • Accept Date: 08 July 2024
  • Publish Date: 01 March 2024

Share

How to cite

Statistics